SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001264124-11-000017
Filing Date
2011-03-03
Accepted
2011-03-03 19:05:28
Documents
1
Period of Report
2011-03-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 10224
  Complete submission text file 0001264124-11-000017.txt   11578
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

IRS No.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DR SAN DIEGO CA 92121
Business Address
Gergen Mark J (Reporting) CIK: 0001373110 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 11661858